Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynergia Energy Regulatory News (SYN)

Share Price Information for Synergia Energy (SYN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.1175
Bid: 0.115
Ask: 0.12
Change: -0.005 (-4.08%)
Spread: 0.005 (4.348%)
Open: 0.1225
High: 0.1225
Low: 0.115
Prev. Close: 0.1225
SYN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

19 Feb 2019 07:00

RNS Number : 4057Q
Synnovia PLC
19 February 2019
 

Synnovia plc

(the "Company" or the "Business" )

 

Trading Update

 

Synnovia plc (AIM: SYN), the specialist manufacturer, provides an update on trading for the financial year to date and announces that it expects trading for the financial year ending 31 March 2019 to be broadly in line with market expectations.

 

Overall Trading

Revenue has continued to grow strongly, but this has not yet translated into the profitability growth that we expected. In part this is due to our ongoing hedging policy, which has negated an improvement that would have arisen from the US$ strength versus sterling over the period. It has also arisen because of cost pressures and unforeseen minor delays to the addition of new capacity in our Films Division. The Industrials Division has continued to perform well.

 

Industrial Division

Bearings sales have grown significantly over recent months, exceeding management's expectations and this growth is expected to continue over the next few months. We continue to add new business and are considering future capacity expansion through a move to a new production facility in Thailand.

 

Matrix activities continue to make good progress over prior year in line with our strategy of getting "closer to the customer" and broadening the range of die-cutting and die-making consumables that we have to offer. We have restructured our management team in China to strengthen our sales and operational capability there. We have also implemented a series of improvements to strengthen performance of our US distribution business.

 

Mandrel sales have recovered somewhat from the temporary reduction that we experienced in Q2/Q3 of the financial year, partly driven by new business wins. We are adding further capacity to our US operations so that more production can be transferred from the UK to the US over the course of the next financial year.

 

Film Division

The Films Division is having a challenging year coping with capacity constraints during the year, continuing strong growth and as management continue to integrate the three former separate businesses. Revenues in the Film Division have so far increased by 10% and in parallel we have implemented significant projects to add capacity and capabilities, including additional extrusion lines, an eight-colour printing press, new conversion machines, recycling equipment and warehousing infrastructure. All this should put us in a very good position for continued sales growth.

 

There have been some delays and teething problems with these projects which we expected to be largely complete in Q3 of the current financial year. However, most of these projects are now expected to conclude in Q4. Meanwhile, staff levels and training have been increased, whilst sales conversions have been held back until the capacity is in place. Costs have therefore risen ahead of revenue, negatively impacting profitability.

 

Commenting, Faisal Rahmatallah, Chairman, said:

 

"Significant organic growth continues to be achieved across both our Divisions. We continue to implement a programme which adds capacity to fulfil this demand and to enable future growth thereafter. Relatively small delays to this programme have been experienced in the Films Division and will restrict profit growth in the current financial year. Except for this disappointment we are satisfied with the progress the Company is making this year.

 

The change of the Company's name to Synnovia plc has seen a smooth transition and is acting as a strong signal to our organisation to do everything reasonably possible to reduce, recycle and re-use plastic waste.

 

Overall, we anticipate that our financial performance over the second half of the financial year will enable us to announce results that are broadly in line with market expectations."

 

 

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

 

 

For further information, please contact:

 

Synnovia plc

Tel: 020 7978 0574

Faisal Rahmatallah, Executive Chairman

 

Nick Ball, Finance Director

 

 

 

Cenkos Securities

Tel: 020 7397 8900

(Nomad and joint broker)

 

Mark Connelly

 

Callum Davidson

 

 

 

Allenby Capital Limited

Tel: 020 3328 5656

(Joint broker)

 

David Hart

 

 

 

Notes to Editor

Synnovia is a specialist manufacturer of industrial components and consumables. Applications for these products vary widely and examples include:

• Packaging for the food manufacturing and distribution - films, sacks and pouches

• Steering columns and instrument control knobs in the automotive industry - plastic ball bearings

• Hydraulic and industrial rubber hose manufacture - various types of plastic mandrel

• Cardboard box manufacture - plastic creasing matrices

 

Synnovia's business model is based on understanding customers' problems in depth, and then developing and mass producing proprietary, technical solutions for these problems.

 

The Business operates through two divisions, Films and Industrial, and has the majority of its production in six UK based factories, with a further three factories in Asia. Approximately 50% of its £83 million sales are made outside the UK to more than 80 countries.

 

Further information can be found on www.synnovia plc.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTEAKAPFSENEFF
Date   Source Headline
7th May 20247:00 amRNSUpdate on GOI Approval, Working Interest Transfer
9th Apr 20247:00 amRNSConversion of Loan Notes and TVR
2nd Apr 20247:00 amRNSAppointment of Executive Director
14th Mar 20247:00 amRNSInterim Financial Report
11th Mar 20247:00 amRNSFinancing Update
16th Feb 20247:00 amRNSResults of General Meeting
14th Feb 20242:27 pmRNSFinalisation of Cambay Field Farm Out and JV
31st Jan 20249:21 amRNSCambay Farm Out Update
25th Jan 20247:00 amRNSAddendum to the Notice of General Meeting
22nd Jan 20247:00 amRNSCambay Farm Out Update
15th Jan 20247:00 amRNSGM - Notice of Meeting
18th Dec 20238:05 amRNSCambay Farm Out and C-77H Update
18th Dec 20237:00 amRNSUpdate to Admission Date
5th Dec 20237:00 amRNSCambay Farm-Out and Funding Arrangements & TVR
16th Nov 20237:00 amRNSResults of Annual General Meeting
3rd Nov 20237:05 amRNSCambay C-77H Artificial Lift Update
23rd Oct 20238:38 amRNSAGM - Notice of Meeting
25th Sep 202312:48 pmRNSCambay C-77H Workover Update
21st Sep 20237:00 amRNSAnnual Report 2023
14th Sep 20237:00 amRNSInvestor Presentation
8th Sep 20237:00 amRNSChange of Company Secretary
23rd Aug 20239:05 amRNSCambay C-77H Workover Update
8th Aug 202311:32 amRNSPlacement – Issue of Securities and TVR
26th Jul 20237:00 amRNSCambay C-77H Workover Update
25th Jul 202310:52 amRNSCambay C-77H Workover Funding Secured and TVR
4th Jul 20237:00 amRNSCambay C-77H Artificial Lift Update
29th Jun 20237:00 amRNSAppointment of Joint Broker / Board Amendments
27th Jun 202310:17 amRNSUK CCS License Applications
1st Jun 20237:00 amRNSCambay C-77H Artificial Lift Update
18th May 202312:27 pmRNSUK CCS License Applications
28th Apr 20237:00 amRNSChange of Registered Office
26th Apr 20233:35 pmRNSUpdate on Farm Out Process
13th Apr 20237:00 amRNSCambay Update
4th Apr 20237:00 amRNSIssue of Options
15th Mar 20237:00 amRNSInterim Financial Report
9th Mar 20237:00 amRNSCambay C-77H Artificial Lift Update
27th Feb 20237:00 amRNSCambay Farm Out and CCS Update
23rd Feb 20234:40 pmRNSSecond Price Monitoring Extn
23rd Feb 20234:35 pmRNSPrice Monitoring Extension
23rd Feb 20232:05 pmRNSSecond Price Monitoring Extn
23rd Feb 20232:00 pmRNSPrice Monitoring Extension
22nd Feb 20237:00 amRNSConvertible Loan Agreement
1st Feb 20237:00 amRNSCambay C-77H Update
30th Jan 20234:40 pmRNSSecond Price Monitoring Extn
30th Jan 20234:35 pmRNSPrice Monitoring Extension
3rd Jan 20237:00 amRNSCambay CCS Scheme Presentation
23rd Dec 20227:00 amRNSUpdate - Removal from the Official List of the ASX
13th Dec 20227:00 amRNSShareholder Presentation
1st Dec 20227:00 amRNSCambay PSC Update
29th Nov 202212:50 pmRNSUpdate - Formal request for removal from ASX

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.